{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:14:59Z","timestamp":1788383699628,"version":"build-2803163510"},"reference-count":45,"publisher":"Japanese Association for Laboratory Animal Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2021]]},"DOI":"10.1538\/expanim.21-0056","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T22:07:02Z","timestamp":1626732422000},"page":"553-562","source":"Crossref","is-referenced-by-count":13,"title":["AP39 ameliorates high fat diet-induced liver injury in young rats via alleviation of oxidative stress and mitochondrial impairment"],"prefix":"10.1538","volume":"70","author":[{"given":"Yue","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, Anhui 230601, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ming","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Orthopedics Surgery, The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, Anhui 230601, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Yun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, Anhui 230601, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, Anhui 230601, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","year":"1999","unstructured":"1. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology.  1999;  116: 1413\u20131419.","journal-title":"Gastroenterology","ISSN":"https:\/\/id.crossref.org\/issn\/0016-5085","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol.  2010;  5: 145\u2013171.","DOI":"10.1146\/annurev-pathol-121808-102132"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Cobbina E, Akhlaghi F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev.  2017;  49: 197\u2013211.","DOI":"10.1080\/03602532.2017.1293683"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Xu L, Nagata N, Ota T. Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction. Int J Mol Sci.  2019;  20: 5920.","DOI":"10.3390\/ijms20235920"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kumar S, Kaufman T. Childhood obesity. Panminerva Med.  2018;  60: 200\u2013212.","DOI":"10.23736\/S0031-0808.18.03557-7"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Takahashi Y, Sugimoto K, Inui H, Fukusato T. Current pharmacological therapies for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. World J Gastroenterol.  2015;  21: 3777\u20133785.","DOI":"10.3748\/wjg.v21.i13.3777"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Olas B. Hydrogen sulfide in signaling pathways. Clin Chim Acta.  2015;  439: 212\u2013218.","DOI":"10.1016\/j.cca.2014.10.037"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ge X, Sun J, Fei A, Gao C, Pan S, Wu Z. Hydrogen sulfide treatment alleviated ventilator-induced lung injury through regulation of autophagy and endoplasmic reticulum stress. Int J Biol Sci.  2019;  15: 2872\u20132884.","DOI":"10.7150\/ijbs.38315"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wang R. Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev.  2012;  92: 791\u2013896.","DOI":"10.1152\/physrev.00017.2011"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wen YD, Wang H, Kho SH, Rinkiko S, Sheng X, Shen HM, et al. Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress. PLoS One.  2013;  8: e53147.","DOI":"10.1371\/journal.pone.0053147"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Mani S, Cao W, Wu L, Wang R. Hydrogen sulfide and the liver. Nitric Oxide.  2014;  41: 62\u201371.","DOI":"10.1016\/j.niox.2014.02.006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ren R, Yang Z, Zhao A, Huang Y, Lin S, Gong J, et al. Sulfated polysaccharide from Enteromorpha prolifera increases hydrogen sulfide production and attenuates non-alcoholic fatty liver disease in high-fat diet rats. Food Funct.  2018;  9: 4376\u20134383.","DOI":"10.1039\/C8FO00518D"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Tan G, Pan S, Li J, Dong X, Kang K, Zhao M, et al. Hydrogen sulfide attenuates carbon tetrachloride-induced hepatotoxicity, liver cirrhosis and portal hypertension in rats. PLoS One.  2011;  6: e25943.","DOI":"10.1371\/journal.pone.0025943"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Szczesny B, M\u00f3dis K, Yanagi K, Coletta C, Le Trionnaire S, Perry A, et al. AP39, a novel mitochondria-targeted hydrogen sulfide donor, stimulates cellular bioenergetics, exerts cytoprotective effects and protects against the loss of mitochondrial DNA integrity in oxidatively stressed endothelial cells in vitro. Nitric Oxide.  2014;  41: 120\u2013130.","DOI":"10.1016\/j.niox.2014.04.008"},{"key":"15","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/SHK.0000000000000478","volume":"45","year":"2016","unstructured":"15. Ahmad A, Olah G, Szczesny B, Wood ME, Whiteman M, Szabo C. AP39, A Mitochondrially Targeted Hydrogen Sulfide Donor, Exerts Protective Effects in Renal Epithelial Cells Subjected to Oxidative Stress in Vitro and in Acute Renal Injury in Vivo. Shock.  2016;  45: 88\u201397.","journal-title":"Shock","ISSN":"https:\/\/id.crossref.org\/issn\/1073-2322","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Covarrubias AE, Lecarpentier E, Lo A, Salahuddin S, Gray KJ, Karumanchi SA, et al. AP39, a Modulator of Mitochondrial Bioenergetics, Reduces Antiangiogenic Response and Oxidative Stress in Hypoxia-Exposed Trophoblasts: Relevance for Preeclampsia Pathogenesis. Am J Pathol.  2019;  189: 104\u2013114.","DOI":"10.1016\/j.ajpath.2018.09.007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Karwi QG, Bornbaum J, Boengler K, Torregrossa R, Whiteman M, Wood ME, et al. AP39, a mitochondria-targeting hydrogen sulfide (H<sub>2<\/sub> S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling. Br J Pharmacol.  2017;  174: 287\u2013301.","DOI":"10.1111\/bph.13688"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhao FL, Fang F, Qiao PF, Yan N, Gao D, Yan Y. AP39, a Mitochondria-Targeted Hydrogen Sulfide Donor, Supports Cellular Bioenergetics and Protects against Alzheimer\u2019s Disease by Preserving Mitochondrial Function in APP\/PS1 Mice and Neurons. Oxid Med Cell Longev.  2016;  2016: 8360738.","DOI":"10.1155\/2016\/8360738"},{"key":"19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/SHK.0000000000001210","volume":"52","year":"2019","unstructured":"19. Wepler M, Merz T, Wachter U, Vogt J, Calzia E, Scheuerle A, et al. The Mitochondria-Targeted H2S-Donor AP39 in a Murine Model of Combined Hemorrhagic Shock and Blunt Chest Trauma. Shock.  2019;  52: 230\u2013239.","journal-title":"Shock","ISSN":"https:\/\/id.crossref.org\/issn\/1073-2322","issn-type":"print"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ahmad A, Szabo C. Both the H<sub>2<\/sub>S biosynthesis inhibitor aminooxyacetic acid and the mitochondrially targeted H<sub>2<\/sub>S donor AP39 exert protective effects in a mouse model of burn injury. Pharmacol Res.  2016;  113:(Pt A): 348\u2013355.","DOI":"10.1016\/j.phrs.2016.09.013"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Shi T, Yang X, Zhou H, Xi J, Sun J, Ke Y, et al. Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis. PLoS One.  2018;  13: e0189856.","DOI":"10.1371\/journal.pone.0189856"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yin Z, Murphy MC, Li J, Glaser KJ, Mauer AS, Mounajjed T, et al. Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography. Eur Radiol.  2019;  29: 5823\u20135831.","DOI":"10.1007\/s00330-019-06076-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Wang W, Wang M, Ruan Y, Tan J, Wang H, Yang T, et al. Ginkgolic Acids Impair Mitochondrial Function by Decreasing Mitochondrial Biogenesis and Promoting FUNDC1-Dependent Mitophagy. J Agric Food Chem.  2019;  67: 10097\u201310106.","DOI":"10.1021\/acs.jafc.9b04178"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Jia N, Lin X, Ma S, Ge S, Mu S, Yang C, et al. Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in <i>Gynostemma pentaphylla<\/i> (Thunb.) Makino treated mice. Nutr Metab (Lond).  2018;  15: 86.","DOI":"10.1186\/s12986-018-0323-6"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ren T, Zhu L, Shen Y, Mou Q, Lin T, Feng H. Protection of hepatocyte mitochondrial function by blueberry juice and probiotics via SIRT1 regulation in non-alcoholic fatty liver disease. Food Funct.  2019;  10: 1540\u20131551.","DOI":"10.1039\/C8FO02298D"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mann JP, Valenti L, Scorletti E, Byrne CD, Nobili V. Nonalcoholic Fatty Liver Disease in Children. Semin Liver Dis.  2018;  38: 1\u201313.","DOI":"10.1055\/s-0038-1627456"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Xia HM, Wang J, Xie XJ, Xu LJ, Tang SQ. Green tea polyphenols attenuate hepatic steatosis, and reduce insulin resistance and inflammation in high-fat diet-induced rats. Int J Mol Med.  2019;  44: 1523\u20131530.","DOI":"10.3892\/ijmm.2019.4285"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Kitade H, Chen G, Ni Y, Ota T. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments. Nutrients.  2017;  9: 387.","DOI":"10.3390\/nu9040387"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Wu D, Wang J, Li H, Xue M, Ji A, Li Y. Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury. Oxid Med Cell Longev.  2015;  2015: 186908.","DOI":"10.1155\/2015\/186908"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci.  2018;  75: 3313\u20133327.","DOI":"10.1007\/s00018-018-2860-6"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Miller CN, Yang JY, Avra T, Ambati S, Della-Fera MA, Rayalam S, et al. A dietary phytochemical blend prevents liver damage associated with adipose tissue mobilization in ovariectomized rats. Obesity (Silver Spring).  2015;  23: 112\u2013119.","DOI":"10.1002\/oby.20907"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Sumida Y, Niki E, Naito Y, Yoshikawa T. Involvement of free radicals and oxidative stress in NAFLD\/NASH. Free Radic Res.  2013;  47: 869\u2013880.","DOI":"10.3109\/10715762.2013.837577"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Zhang L, Li HX, Pan WS, Ullah Khan F, Qian C, Qi-Li FR, et al. Administration of methyl palmitate prevents non-alcoholic steatohepatitis (NASH) by induction of PPAR-\u03b1. Biomed Pharmacother.  2019;  111: 99\u2013108.","DOI":"10.1016\/j.biopha.2018.12.059"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ger\u0151 D, Torregrossa R, Perry A, Waters A, Le-Trionnaire S, Whatmore JL, et al. The novel mitochondria-targeted hydrogen sulfide (H<sub>2<\/sub>S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. Pharmacol Res.  2016;  113:(Pt A): 186\u2013198.","DOI":"10.1016\/j.phrs.2016.08.019"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Paradies G, Paradies V, Ruggiero FM, Petrosillo G. Oxidative stress, cardiolipin and mitochondrial dysfunction in nonalcoholic fatty liver disease. World J Gastroenterol.  2014;  20: 14205\u201314218.","DOI":"10.3748\/wjg.v20.i39.14205"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Jha SK, Jha NK, Kumar D, Ambasta RK, Kumar P. Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration. Biochim Biophys Acta Mol Basis Dis.  2017;  1863: 1132\u20131146.","DOI":"10.1016\/j.bbadis.2016.06.015"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Malik AN, Czajka A. Is mitochondrial DNA content a potential biomarker of mitochondrial dysfunction? Mitochondrion.  2013;  13: 481\u2013492.","DOI":"10.1016\/j.mito.2012.10.011"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Malik AN, Sim\u00f5es ICM, Rosa HS, Khan S, Karkucinska-Wieckowska A, Wieckowski MR. A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease. Cells.  2019;  8: 1222.","DOI":"10.3390\/cells8101222"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Sim\u00f5es ICM, Fontes A, Pinton P, Zischka H, Wieckowski MR. Mitochondria in non-alcoholic fatty liver disease. Int J Biochem Cell Biol.  2018;  95: 93\u201399.","DOI":"10.1016\/j.biocel.2017.12.019"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Chowdhury A, Aich A, Jain G, Wozny K, L\u00fcchtenborg C, Hartmann M, et al. Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1\u03b1 Expression in Hypoxia. Cell Rep.  2018;  25: 561\u2013570.e6.","DOI":"10.1016\/j.celrep.2018.09.057"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Gonzalez FJ, Xie C, Jiang C. The role of hypoxia-inducible factors in metabolic diseases. Nat Rev Endocrinol.  2018;  15: 21\u201332.","DOI":"10.1038\/s41574-018-0096-z"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Carabelli J, Burgue\u00f1o AL, Rosselli MS, Gianotti TF, Lago NR, Pirola CJ, et al. High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia. J Cell Mol Med.  2011;  15: 1329\u20131338.","DOI":"10.1111\/j.1582-4934.2010.01128.x"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Antonucci L, Porcu C, Iannucci G, Balsano C, Barbaro B. Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper. Nutrients.  2017;  9: 1137.","DOI":"10.3390\/nu9101137"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Lensu S, Pariyani R, M\u00e4kinen E, Yang B, Saleem W, Munukka E, et al. Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats. Nutrients.  2020;  12: 3225.","DOI":"10.3390\/nu12113225"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Pessayre D. Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol.  2007;  22:(Suppl 1): S20\u2013S27.","DOI":"10.1111\/j.1440-1746.2006.04640.x"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/70\/4\/70_21-0056\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T03:43:24Z","timestamp":1636775004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/70\/4\/70_21-0056\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.21-0056","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"21-0056"}}